These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15457278)

  • 21. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.
    Nienhuis MB; Ottervanger JP; Bilo HJ; Dikkeschei BD; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):318-24. PubMed ID: 18288753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increase in troponin levels after coronary angioplasty (PTCA) in stable angina pectoris].
    Varvarovský I; Brtko M; Branny M
    Vnitr Lek; 2004 Mar; 50(3):203-7. PubMed ID: 15125370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention.
    Miller WL; Garratt KN; Burritt MF; Reeder GS; Jaffe AS
    Chest; 2004 Jan; 125(1):275-80. PubMed ID: 14718451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
    Bolognese L; Ducci K; Angioli P; Falsini G; Liistro F; Baldassarre S; Burali A
    Circulation; 2004 Sep; 110(12):1592-7. PubMed ID: 15353489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury.
    Gustavsson CG; Hansen O; Frennby B
    Scand Cardiovasc J; 2004 May; 38(2):75-9. PubMed ID: 15204231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.
    Kizer JR; Muttrej MR; Matthai WH; McConnell J; Nardone H; Sonel AF; Keane MG; Wilensky RL
    Eur Heart J; 2003 Jul; 24(14):1314-22. PubMed ID: 12871688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up.
    Otto S; Seeber M; Fujita B; Kretzschmar D; Ferrari M; Goebel B; Figulla HR; Poerner TC
    Basic Res Cardiol; 2012 Sep; 107(5):289. PubMed ID: 22850870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.
    Nageh T; Sherwood RA; Harris BM; Thomas MR
    Heart; 2005 Sep; 91(9):1181-5. PubMed ID: 16103554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
    Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
    Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction.
    Panteghini M; Bonetti G; Pagani F; Stefini F; Giubbini R; Cuccia C
    Clin Chem Lab Med; 2005; 43(8):848-54. PubMed ID: 16201896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in serum concentrations of markers of myocardial injury following treadmill exercise testing in patients with suspected ischaemic heart disease.
    Ashmaig ME; Starkey BJ; Ziada AM; Amro AA; Sobki SH; Ferns GA
    Med Sci Monit; 2001; 7(1):54-7. PubMed ID: 11208493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.